| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |